AP-1 mediated transcriptional repression of matrix metalloproteinase-9 by recruitment of histone deacetylase 1 in response to interferon β

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Mittelstadt, Megan L ^a   Patel, Rekha C ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GELATINASE B; HISTONE DEACETYLASE 1; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; GENE DELETION; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; POINT MUTATION; PROMOTER REGION; REPORTER GENE; TRANSCRIPTION REPRESSION;

BASE PAIRING; BINDING SITES; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; HISTONE DEACETYLASE 1; HUMANS; INTERFERON-BETA; MATRIX METALLOPROTEINASE 9; MODELS, GENETIC; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REPRESSOR PROTEINS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 84864700656     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042152     Document Type: Article

References (29)

1. Rani MR, Ransohoff RM, ((2005)) Alternative and accessory pathways in the regulation of IFN-beta-mediated gene expression. J Interferon Cytokine Res 25:788-798.
2. Zhao X, Nozell S, Ma Z, Benveniste EN, ((2007)) The interferon-stimulated gene factor 3 complex mediates the inhibitory effect of interferon-beta on matrix metalloproteinase-9 expression. FEBS J 274:6456-6468.
3. Der SD, Zhou A, Williams BR, Silverman RH, ((1998)) Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 95:15623-15628.
4. Ma Z, Qin H, Benveniste EN, ((2001)) Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J Immunol 167:5150-5159.
5. Hartung HP, ((2000)) NICE and drugs for multiple sclerosis. National Institute of Clinical Excellence. Lancet 356:1114.
6. Ram M, Sherer Y, Shoenfeld Y, ((2006)) Matrix Metalloproteinase-9 and Autoimmune Diseases. Journal of Clinical Immunology 26:299-307.
7. Eastham AM, Spencer H, Soncin F, Ritson S, Merry CL, et al. ((2007)) Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res 67:11254-11262.
8. Galewska Z, Romanowicz L, Jaworski S, Bankowski E, ((2008)) Gelatinase matrix metalloproteinase (MMP)-2 and MMP-9 of the umbilical cord blood in preeclampsia. Clin Chem Lab Med 46:517-522.
9. Han YJ, Kim HN, Yoon JK, Yi SY, Moon HS, et al. ((2009)) Haplotype analysis of the matrix metalloproteinase-9 gene associated with advanced-stage endometriosis. Fertil Steril 91:2324-2330.
10. Weiss A, Goldman S, Shalev E, ((2007)) The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front Biosci 12:649-659.
11. Yan C, Wang H, Toh Y, Boyd DD, ((2003)) Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation. J Biol Chem 278:2309-2316.
12. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, et al. ((2002)) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 37:375-536.
13. Sanceau J, ((2002)) Interferons Inhibit Tumor Necrosis Factor-alpha-mediated Matrix Metalloproteinase-9 Activation via Interferon Regulatory Factor-1 Binding Competition with NF-kappa B. Journal of Biological Chemistry. 277:35766-35775.
14. Zhao Z, Qian Y, Wald D, Xia YF, Geng JG, et al. ((2003)) IFN regulatory factor-1 is required for the up-regulation of the CD40-NF-kappa B activator 1 axis during airway inflammation. J Immunol 170:5674-5680.
15. Gum R, Lengyel E, Juarez J, Chen JH, Sato H, et al. ((1996)) Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem 271:10672-10680.
16. Hebbar PB, Archer TK, ((2008)) Altered histone H1 stoichiometry and an absence of nucleosome positioning on transfected DNA. J Biol Chem 283:4595-4601.
17. Iyer NG, Ozdag H, Caldas C, ((2004)) p300/CBP and cancer. Oncogene 23:4225-4231.
18. Ma Z, Chang MJ, Shah RC, Benveniste EN, ((2005)) Interferon-gamma-activated STAT-1alpha suppresses MMP-9 gene transcription by sequestration of the coactivators CBP/p300. J Leukoc Biol 78:515-523.
19. Hartung HP, Kieseier BC, ((2000)) The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system. J Neuroimmunol 107:140-147.
20. Nozell S, Ma Z, Wilson C, Shah R, Benveniste EN, ((2004)) Class II major histocompatibility complex transactivator (CIITA) inhibits matrix metalloproteinase-9 gene expression. J Biol Chem 279:38577-38589.
21. Hu X, Paik PK, Chen J, Yarilina A, Kockeritz L, et al. ((2006)) IFN-γ Suppresses IL-10 Production and Synergizes with TLR2 by Regulating GSK3 and CREB/AP-1 Proteins. Immunity 24:563-574.
22. Weiss C, Schneider S, Wagner EF, Zhang X, Seto E, et al. ((2003)) JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun. EMBO J 22:3686-3695.
23. Kim T, Yoon J, Cho H, Lee W-b, Kim J, et al. ((2005)) Downregulation of lipopolysaccharide response in drosophila by negative crosstalk between the AP1 and NF-κB signaling modules. Nature Immunology 6:211-218.
24. Kim LK, Choi UY, Cho HS, Lee JS, Lee WB, et al. ((2007)) Down-regulation of NF-kappaB target genes by the AP-1 and STAT complex during the innate immune response in Drosophila. PLoS Biol 5:e238.
25. Ma Z, Chang MJ, Shah R, Adamski J, Zhao X, et al. ((2004)) Brg-1 is required for maximal transcription of the human matrix metalloproteinase-2 gene. J Biol Chem 279:46326-46334.
26. Yao XH, Nyomba BL, ((2008)) Hepatic insulin resistance induced by prenatal alcohol exposure is associated with reduced PTEN and TRB3 acetylation in adult rat offspring. Am J Physiol Regul Integr Comp Physiol 294:R1797-1806.
27. Ikenoue T, Inoki K, Zhao B, Guan KL, ((2008)) PTEN acetylation modulates its interaction with PDZ domain. Cancer Res 68:6908-6912.
28. Fantini D, Vascotto C, Deganuto M, Bivi N, Gustincich S, et al. ((2008)) APE1/Ref-1 regulates PTEN expression mediated by Egr-1. Free Radic Res 42:20-29.
29. Rasheed S, Nelson-Rees WA, Toth EM, Arnstein P, Gardner MB, ((1974)) Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33:1027-1033.